• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于环丙烷的组胺构象限制。(1S,2S)-2-(2-氨基乙基)-1-(1H-咪唑-4-基)环丙烷,一种组胺H3受体的高选择性激动剂,具有顺式环丙烷结构。

Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.

作者信息

Kazuta Yuji, Hirano Kazufumi, Natsume Kentaro, Yamada Shizuo, Kimura Ryohei, Matsumoto Shun-Ichiro, Furuichi Kiyoshi, Matsuda Akira, Shuto Satoshi

机构信息

Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.

出版信息

J Med Chem. 2003 May 8;46(10):1980-8. doi: 10.1021/jm020415q.

DOI:10.1021/jm020415q
PMID:12723960
Abstract

A series of cyclopropane-based conformationally restricted analogues of histamine, the "folded" cis-analogues, i.e., (1S,2R)-2-(aminomethyl)-1-(1H-imidazol-4-yl)cyclopropane (11), (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane (13), and their enantiomers ent-11 and ent-13, and the "extended" trans-analogues, i.e., (1R,2R)-2-(aminomethyl)-1-(1H-imidazol-4-yl)cyclopropane (12) and its enantiomer ent-12, were designed as histamine H(3) receptor agonists. These target compounds were synthesized from the versatile chiral cyclopropane units, (1S,2R)- and (1R,2R)-2-(tert-butyldiphenylsilyloxy)methyl-1-formylcyclopropane (14 and 15, respectively) or their enantiomers ent-14 and ent-15. Among the conformationally restricted analogues, the "folded" analogue 13 (AEIC) having the cis-cyclopropane structure was identified as a potent H(3) receptor agonist, which showed a significant binding affinity (K(i) = 1.31 +/- 0.16 nM) and had an agonist effect (EC(50) value of 10 +/- 3 nM) on the receptor. This compound owes its importance to being the first highly selective H(3) receptor agonist to have virtually no effect on the H(4) subtype receptor. These studies showed that the cis-cyclopropane structure is very effective in the conformational restriction of histamine to improve the specific binding to the histamine H(3) receptor.

摘要

设计了一系列基于环丙烷的组胺构象受限类似物,即“折叠”的顺式类似物,如(1S,2R)-2-(氨甲基)-1-(1H-咪唑-4-基)环丙烷(11)、(1S,2S)-2-(2-氨乙基)-1-(1H-咪唑-4-基)环丙烷(13)及其对映体ent-11和ent-13,以及“伸展”的反式类似物,如(1R,2R)-2-(氨甲基)-1-(1H-咪唑-4-基)环丙烷(12)及其对映体ent-12,作为组胺H(3)受体激动剂。这些目标化合物由通用的手性环丙烷单元(1S,2R)-和(1R,2R)-2-(叔丁基二苯基硅氧基)甲基-1-甲酰基环丙烷(分别为14和15)或其对映体ent-14和ent-15合成。在构象受限类似物中,具有顺式环丙烷结构的“折叠”类似物13(AEIC)被鉴定为一种有效的H(3)受体激动剂,它对该受体显示出显著的结合亲和力(K(i)=1.31±0.16 nM)并具有激动剂效应(EC(50)值为10±3 nM)。该化合物的重要性在于它是第一种对H(4)亚型受体几乎没有影响的高选择性H(3)受体激动剂。这些研究表明,顺式环丙烷结构在组胺的构象限制中非常有效,可改善与组胺H(3)受体的特异性结合。

相似文献

1
Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.基于环丙烷的组胺构象限制。(1S,2S)-2-(2-氨基乙基)-1-(1H-咪唑-4-基)环丙烷,一种组胺H3受体的高选择性激动剂,具有顺式环丙烷结构。
J Med Chem. 2003 May 8;46(10):1980-8. doi: 10.1021/jm020415q.
2
Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.面向立体化学多样性的构象限制策略。具有咪唑基环丙烷结构的强效组胺H3和/或H4受体拮抗剂的研发。
J Med Chem. 2006 Sep 7;49(18):5587-96. doi: 10.1021/jm0603318.
3
Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: histamine H3 and/or H4 receptor ligands with the 2,3-methanobutane backbone.基于环丙烷的立体化学多样性导向构象限制策略:具有 2,3-甲烷丁烷骨架的组胺 H3 和/或 H4 受体配体。
Org Biomol Chem. 2012 Jan 28;10(4):736-45. doi: 10.1039/c1ob06496g. Epub 2011 Nov 28.
4
Development of versatile cis- and trans-dicarbon-substituted chiral cyclopropane units: synthesis of (1S,2R)- and (1R,2R)-2-aminomethyl-1-(1H-imidazol-4-yl)cyclopropanes and their enantiomers as conformationally restricted analogues of histamine.通用的顺式和反式二碳取代手性环丙烷单元的开发:(1S,2R)-和(1R,2R)-2-氨基甲基-1-(1H-咪唑-4-基)环丙烷及其对映体的合成,作为组胺的构象受限类似物。
J Org Chem. 2002 Mar 8;67(5):1669-77. doi: 10.1021/jo010852x.
5
Characterization of the binding site of the histamine H3 receptor. 1. Various approaches to the synthesis of 2-(1H-imidazol-4-yl)cyclopropylamine and histaminergic activity of (1R,2R)- and (1S,2S)-2-(1H-imidazol-4-yl)-cyclopropylamine.组胺H3受体结合位点的表征。1. 2-(1H-咪唑-4-基)环丙胺的各种合成方法以及(1R,2R)-和(1S,2S)-2-(1H-咪唑-4-基)环丙胺的组胺能活性。
J Med Chem. 1999 Apr 8;42(7):1115-22. doi: 10.1021/jm9810912.
6
A selective human H(4)-receptor agonist: (-)-2-cyano-1-methyl-3-[(2R,5R)-5- [1H-imidazol-4(5)-yl]tetrahydrofuran-2-y] methylguanidine.一种选择性人H(4)受体激动剂:(-)-2-氰基-1-甲基-3-[(2R,5R)-5-[1H-咪唑-4(5)-基]四氢呋喃-2-基]甲基胍。
J Med Chem. 2003 Jul 3;46(14):3162-5. doi: 10.1021/jm0300025.
7
Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives.一系列新型手性组胺H3受体配体的合成及体外药理学研究:2-(R和S)-氨基-3-(1H-咪唑-4(5)-基)丙基醚衍生物
J Med Chem. 1999 Apr 8;42(7):1193-202. doi: 10.1021/jm980408v.
8
Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonists.基于乙炔的组胺H3受体拮抗剂的设计、合成及构效关系
J Med Chem. 1999 Mar 11;42(5):903-9. doi: 10.1021/jm980310g.
9
Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H(3) receptor agonist.鉴定4-(1H-咪唑-4(5)-基甲基)吡啶(伊美替啶)为一种新型、强效且高度选择性的组胺H(3)受体激动剂。
J Med Chem. 2004 May 6;47(10):2414-7. doi: 10.1021/jm049932u.
10
Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.组胺 H3 受体结合部位的研究。具有亲脂侧链的混合激动剂的设计与合成。
J Med Chem. 2010 Sep 9;53(17):6445-56. doi: 10.1021/jm100643t.

引用本文的文献

1
2-Heteroarylethylamines in medicinal chemistry: a review of 2-phenethylamine satellite chemical space.药物化学中的2-杂芳基乙胺:2-苯乙胺卫星化学空间综述
Beilstein J Org Chem. 2024 Aug 2;20:1880-1893. doi: 10.3762/bjoc.20.163. eCollection 2024.
2
Modular Enantioselective Synthesis of -Cyclopropanes through Self-Sensitized Stereoselective Photodecarboxylation with Benzothiazolines.通过苯并噻唑啉的自敏化立体选择性光脱羧反应实现环丙烷的模块化对映选择性合成。
ACS Catal. 2021 Nov 5;11(21):13312-13319. doi: 10.1021/acscatal.1c03949. Epub 2021 Oct 18.
3
Synthesis and biological activity of conformationally restricted indole-based inhibitors of neurotropic alphavirus replication: Generation of a three-dimensional pharmacophore.
构象限制吲哚类神经营养性甲型肝炎病毒复制抑制剂的合成与生物活性:三维药效团的生成。
Bioorg Med Chem Lett. 2021 Aug 15;46:128171. doi: 10.1016/j.bmcl.2021.128171. Epub 2021 Jun 15.
4
Conformational Restriction of Histamine with a Rigid Bicyclo[3.1.0]hexane Scaffold Provided Selective H Receptor Ligands.刚性双环[3.1.0]己烷支架限制组胺的构象,提供选择性 H 受体配体。
Molecules. 2020 Aug 5;25(16):3562. doi: 10.3390/molecules25163562.
5
Rational approaches for the design of various GABA modulators and their clinical progression.各种 GABA 调节剂的设计及临床进展的合理方法。
Mol Divers. 2021 Feb;25(1):551-601. doi: 10.1007/s11030-020-10068-4. Epub 2020 Mar 13.
6
4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H Receptor Agonists with in Vivo Central Nervous System Activity.4-(3-氨基氮杂啶-1-基)嘧啶-2-胺类作为高亲和力非咪唑组胺 H 受体激动剂,具有体内中枢神经系统活性。
J Med Chem. 2019 Dec 12;62(23):10848-10866. doi: 10.1021/acs.jmedchem.9b01462. Epub 2019 Nov 20.
7
S-Catalyzed triple cleavage of bromodifluoro compounds for the assembly of N-containing heterocycles.S催化的溴二氟化合物的三重裂解用于含氮杂环的组装。
Chem Sci. 2019 Jun 5;10(28):6828-6833. doi: 10.1039/c9sc01333d. eCollection 2019 Jul 28.